Concepedia

Lydia Jasmin Hanisch

LJ

Statistics

Publications

3

Citations

113

H-Index

3

Active since

2015

Affiliations

Roche (Switzerland)(Current)

Roche Pharma AG (Germany)

Lydia Jasmin Hanisch is an author at Roche (Switzerland) specializing in life sciences, molecular biology, and tumor-associated antigen targeting.

ORCID

Publications per year

2015–2024

3

Publications

3

Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody

Christian Augsberger, Gerulf Hänel, Wei Xu et al. · Blood · 2021 · 68 citations · Full text

, , +14

Receptor-targeted lentiviral vectors are exceptionally sensitive toward the biophysical properties of the displayed single-chain Fv

Thorsten Friedel, Lydia Jasmin Hanisch, Anke Muth et al. · Protein Engineering Design and Selection · 2015 · 28 citations · Full text

, , +14

The physiological interactome of TCR-like antibody therapeutics in human tissues

Estelle Marrer‐Berger, Annalisa Nicastri, Angélique Augustin et al. · Nature Communications · 2024 · 17 citations · Full text

, , +17

1–3 of 3